Characteristics | Total | Non-HC group | HC group | p value |
---|---|---|---|---|
Number of patients, n (%) | 2121 | 1909(90%) | 212(10%) | Â |
Gender | Â | Â | Â | 0.133 |
 Male | 1349(63.6%) | 1224(64.2%) | 125(58.7%) |  |
 Female | 772(36.4%) | 684(35.8%) | 88(41.3%) |  |
Age on death, years | 75.8 ± 6.5 | 75.3 ± 6.6 | 74.7 ± 6.4 | 0.233 |
Survival after cancer diagnosis, years [mean (median)] | 1.94(0.80) | 1.92(0.84) | 2.10(0.88) | 0.523 |
Diabetes | 296(14.0%) | 268(10.4%) | 28(13.1%) | 0.835 |
Hypertension | 426(20.1%) | 383(20.1%) | 43(20.2%) | 1 |
Stroke | 164(7.7%) | 144(7.5%) | 20(9.4%) | 0.343 |
HBV | 436(20.6%) | 384(20.1%) | 52(24.4%) | 0.152 |
HCV | 621(29.3%) | 556(29.1%) | 65(30.5%) | 0.692 |
Liver cirrhosis | 1275(60.1%) | 1139(59.7%) | 136(63.8%) | 0.268 |
EVB | 18.7(8.8%) | 149(7.8%) | 38(17.8%) | <0.001 |
Ascites | 519(24.5%) | 479(25.1%) | 40(18.8%) | 0.044 |
CKD | 155(7.3%) | 129(6.8%) | 26(12.2%) | 0.008 |
Hemodialysis | 95(4.5%) | 62(3.2%) | 33(15.5%) | <0.001 |
CCI (scores) | 3.64 ± 2.36 | 3.62 ± 2.32 | 3.80 ± 2.65 | 0.534 |
Opioids use | 459(21.6%) | 393(20.6%) | 66(31.0%) | 0.001 |
Urbanization level | ||||
 Urban | 949(44.7%) | 842(44.1%) | 107(50.2%) | 0.095 |
 Suburban | 775(36.5%) | 702(36.8%) | 73(34.3%) | 0.500 |
 Rural | 397(18.7%) | 364(19.1%) | 33(15.5%) | 0.229 |